QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:ERYP

ERYTECH Pharma SEC Filings & 10K Form

$5.93
-0.01 (-0.17 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.93
$6.20
50-Day Range
$5.59
$6.47
52-Week Range
$4.10
$13.00
Volume64,158 shs
Average Volume370,034 shs
Market Capitalization$164.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.56

ERYTECH Pharma (NASDAQ:ERYP) SEC Filings

DateFilerForm TypeView
09/21/2021
11:50 AM
ERYTECH Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
09/21/2021
8:42 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2021
12:37 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2021
9:09 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2021
7:18 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
8:55 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2021
5:13 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2021
4:20 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2021
4:14 PM
ERYTECH Pharma (Filer)
Form 424B5
05/03/2021
5:07 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/21/2021
7:01 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2021
8:48 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2021
8:40 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13G
03/09/2021
8:55 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2021
12:43 PM
ERYTECH Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/08/2021
8:15 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2021
3:36 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
01/27/2021
9:17 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2021
11:35 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/12/2021
4:10 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
12/15/2020
7:16 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2020
9:14 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2020
8:24 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/03/2020
3:33 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/13/2020
4:18 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
10/13/2020
4:18 PM
ERYTECH Pharma (Subject)
ERYTECH Pharma (Subject)
Form SC 13D/A
10/12/2020
11:15 PM
ERYTECH Pharma (Filer)
Form EFFECT
10/12/2020
11:15 PM
ERYTECH Pharma (Filer)
ERYTECH Pharma (Filer)
Form EFFECT
10/09/2020
4:16 PM
ERYTECH Pharma (Filer)
Form 424B5
10/08/2020
4:24 PM
ERYTECH Pharma (Filer)
Form F-3/A
10/07/2020
3:05 PM
ERYTECH Pharma (Filer)
Form F-3/A
09/21/2020
4:26 PM
ERYTECH Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
09/21/2020
5:09 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/15/2020
6:32 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2020
4:10 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2020
3:31 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2020
3:10 PM
ERYTECH Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/02/2020
4:07 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
3:40 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2020
6:59 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/21/2020
6:06 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2020
3:03 PM
ERYTECH Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
11/08/2019
7:44 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2019
3:14 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2019
8:30 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2019
11:15 PM
ERYTECH Pharma (Filer)
Form EFFECT
07/30/2019
3:18 PM
ERYTECH Pharma (Filer)
Form 424B3
07/16/2019
3:27 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2019
3:24 PM
ERYTECH Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/16/2019
3:20 PM
ERYTECH Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
06/26/2019
4:16 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2019
3:51 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2019
12:52 PM
ERYTECH Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/04/2019
7:51 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2018
4:21 PM
BAKER BROS. ADVISORS LP (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
11/08/2018
4:03 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
07/18/2018
8:14 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D
07/17/2018
3:56 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2018
4:23 PM
BAKER BROS. ADVISORS LP (Filed by)
ERYTECH Pharma (Subject)
Form SC 13D/A
07/02/2018
3:30 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13G/A
06/25/2018
5:06 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/15/2018
6:41 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2018
6:03 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2018
6:04 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2018
4:24 PM
ERYTECH Pharma (Filer)
Form 20-F/A
05/02/2018
11:07 AM
BANK OF NEW YORK / ADR DIVISION (Filed by)
ERYTECH Pharma (Subject)
Form F-6 POS
04/24/2018
3:16 PM
ERYTECH Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/12/2018
5:07 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2018
4:18 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2018
5:02 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2018
3:48 PM
ERYTECH Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/02/2018
4:03 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ERYTECH Pharma (Subject)
Form SC 13G
12/08/2017
6:04 AM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2017
3:41 PM
ERYTECH Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.